This opportunity is no longer accepting applications.
grant PAR-23-130

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

This grant aims to fund research focused on improving precision medicine for pregnant and lactating individuals, as well as children. It supports the development of new tools and technologies to enhance clinical impacts, understanding drug actions and physiological changes during pregnancy and lactation, and discovering safer, more effective treatments or repurposing existing drugs. The ultima…

The purpose of this funding opportunity announcement (FOA) is to support translational and clinical research to (1) advance precision medicine in pregnant persons, lactating persons, and children through the development of novel tools, models, and other technologies that could have a direct clin…

Funding Source

Agency: National Institutes of Health
Sub-agency: <em>Eunice Kennedy Shriver</em> National Institute of Child Health and Human Development
Program: SBIR

Dates

Opportunity Released: March 1, 2023
Open for Submission: March 1, 2023
Submission Deadline: May 7, 2026
Application Window Closes: May 7, 2026

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.